A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

CN Sternberg, RE Hawkins, J Wagstaff, P Salman, J Mardiak, CH Barrios, JJ Zarba, OA Gladkov, E Lee, C Szczylik, L McCann, SD Rubin, M Chen, ID Davis

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)1287-1296
    Number of pages9
    JournalEuropean Journal of Cancer
    Issue number6
    Publication statusPublished - 2013

    Cite this